Colostrinin-driven neurite outgrowth requires p53 activation in PC12 cells

Cellular and Molecular Neurobiology

Volumn 25, Issue 7, 2005, Pages 1123-1139

  Bacsi, Attila ^a,d   Stanton, G John ^a   Hughes, Thomas K ^a   Kruze, Marian ^b,c   Boldogh, Istvan ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c ReGen Therapeutics Plc   (United Kingdom)

^d UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Colostrinin; Neurite outgrowth; p53 activation; Pheochromocytoma cell

Indexed keywords

AURORA A KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1; LUCIFERASE; NEUROTROPHIN; OLIGONUCLEOTIDE; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CELL STRAIN; COLOSTRUM; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NERVE FIBER GROWTH; OXIDATIVE STRESS; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THYMOCYTE;

MURINAE;

EID: 29944443102     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-005-8222-6     Document Type: Article

References (60)

1. Aloni-Grinstein, R., Zan-Bar, I., Alboum, I., Goldfinger, N., and Rotter, V. (1993). Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage. Oncogene 8:3297-3305.
2. Armstrong, J. F., Kaufman, M. H., Harrison, D. J., and Clarke, A. R. (1995). High-frequency developmental abnormalities in p53-deficient mice. Curr. Biol. 5:931-936.
3. Benowitz, L. I., and Routtenberg, A. (1997). GAP-43: An intrinsic determinant of neuronal development and plasticity. Trends Neurosci. 20:84-91.
4. Bilikiewicz, A., and Gaus, W. (2004). Colostrinin (a naturally occurring, proline-rich, polypeptide mixture) in the treatment of Alzheimer's disease. J. Alzheimers Dis. 6:17-26.
5. Boldogh, I., Hughes, T. K., Georgiades, J. A., and Stanton, G. J. (2001). Antioxidant effect of colostrinin and its component peptides. Psychogeriat. Annu. 4:57-65.
6. Boldogh, I., Liebenthal, D., Hughes, T. K., Juelich, T. L., Georgiades, J. A., Kruzel, M. L., and Stanton, G. J. (2003a). Modulation of 4HNE-mediated signaling by proline-rich peptides from ovine colostrum. J. Mol. Neurosci. 20:125-134.
7. Boldogh, I., Milligan, D., Lee, M. S., Bassett, H., Lloyd, R. S., and McCullough, A. K. (2001). hMYH cell cycle-dependent expression, subcellular localization and association with replication foci: Evidence suggesting replication-coupled repair of adenine:8-oxoguanine mispairs. Nucleic Acids Res. 29:2802-2809.
8. Boldogh, I., Roy, G., Lee, M. S., Bacsi, A., Hazra, T. K., Bhakat, K. K., Das, G. C., and Mitra, S. (2003b). Reduced DNA double strand breaks in chlorambucil resistant cells are related to high DNA-PKcs activity and low oxidative stress. Toxicology 193:137-152.
9. Bresnahan, W. A., Boldogh, I., Chi, P., Thompson, E. A., and Albrecht, T. (1997). Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication. Virology 231:239-247.
10. Carter, A. N., and Downes, C. P. (1992). Phosphatidylinositol 3-kinase is activated by nerve growth factor and epidermal growth factor in PC12 cells. J. Biol. Chem. 267:14563-14567.
11. Chen, R. W., Saunders, P. A., Wei, H., Li, Z., Seth, P., and Chuang, D. M. (1999). Involvement of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and p53 in neuronal apoptosis: Evidence that GAPDH is upregulated by p53. J. Neurosci. 19:9654-9662.
12. Costello, B., Meymandi, A., and Freeman, J. A. (1990). Factors influencing GAP-43 gene expression in PC12 pheochromocytoma cells. J. Neurosci. 10:1398-1406.
13. D'Arcangelo, G., and Halegoua, S. (1993). A branched signaling pathway for nerve growth factor is revealed by Src-, Ras-, and Raf-mediated gene inductions. Mol. Cell. Biol. 13:3146-3155.
14. Eizenberg, O., Faber-Elman, A., Gottlieb, E., Oren, M., Rotter, V., and Schwartz, M. (1996). p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol. Cell. Biol. 16:5178-5185.
15. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498.
16. el-Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Canman, C. E., Jackman, J., Pietenpol, J. A., Burrell, M., Hill, D. E., Wang, Y., Winman, K. G., Mercer, E. W., Kastan,M. B., Kohn, K. W., Elledge, S. J., Kinzler, K. W. and Vogelstein, B. (1994). WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1169-1174.
17. Goslin, K., and Banker, G. (1990). Rapid changes in the distribution of GAP-43 correlate with the expression of neuronal polarity during normal development and under experimental conditions. J. Cell. Biol. 110:1319-1331.
18. Greene, L. A., and Tischler, A. S. (1976). Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73:2424-2428.
19. Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D., and Lassar, A. B. (1995). Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021.
20. Harris, S. L., and Levine, A. J. (2005). The p53 pathway: Positive and negative feedback loops. Oncogene 24:2899-2908.
21. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. (1991). p53 mutations in human cancers. Science 253:49-53.
22. Hosang, M., and Shooter, E. M. (1987). The internalization of nerve growth factor by high-affinity receptors on pheochromocytoma PC12 cells. EMBO J. 6:1197-1202.
23. Hughes, A. L., Gollapudi, L., Sladek, T. L., and Neet, K. E. (2000). Mediation of nerve growth factor-driven cell cycle arrest in PC12 cells by p53. Simultaneous differentiation and proliferation subsequent to p53 functional inactivation. J. Biol. Chem. 275:37829-37837.
24. Janusz, M., and Lisowski, J. (1993). Proline-rich polypeptide (PRP) - An immunomodulatory peptide from ovine colostrum. Arch. Immunol. Ther. Exp. (Warsz) 41:275-279.
25. Janusz, M., Lisowski, J., and Franek, F. (1974). Isolation and characterization of a proline-rich polypeptide from ovine colostrum. FEBS Lett. 49:276-279.
26. Janusz, M., Staroscik, K., Zimecki, M., Wieczorek, Z., and Lisowski, J. (1981). Chemical and physical characterization of a proline-rich polypeptide from sheep colostrum. Biochem. J. 199:9-15.
27. Jap Tjoen San, E. R., Schmidt-Michels, M. H., Spruijt, B. M., Oestreicher, A. B., Schotman, P., and Gispen, W. H. (1991). Quantitation of the growth-associated protein B-50/G AP-43 and neurite outgrowth in PC12 cells. J. Neurosci. Res. 29:149-154.
28. Klesse, L. J., and Parada, L. F. (1999). Trks: Signal transduction and intracellular pathways. Microsc. Res. Tech. 45:210-216.
29. Kruzel, M. L., Janusz, M., Lisowski, J., Fischleigh, R. V., and Georgiades, J. A. (2001). Towards an understanding of biological role of colostrinin peptides. J. Mol. Neurosci. 17:379-389.
30. Kruzel, M. L., Polanowski, A., Wilusz, T., Sokolowska, A., Pacewicz, M., Bednarz, R., and Georgiades, J. A. (2004). The alcohol-induced conformational changes in casein micelles: A new challenge for the purification of colostrinin. Protein J. 23:127-133.
31. Leszek, J., Inglot, A. D., Janusz, M., Lisowski, J., Krukowska, K., and Georgiades, J. A. (1999). Colostrinin: A proline-rich polypeptide (PRP) complex isolated from ovine colostrum for treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Arch. Immunol. Ther. Exp. (Warsz) 47:377-385.
32. Levi, A., Biocca, S., Cattaneo, A., and Calissano, P. (1988). The mode of action of nerve growth factor in PC12 cells. Mol. Neurobiol. 2:201-226.
33. Levine, A. J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
34. Liebermann, D. A., Hoffman, B., and Steinman, R. A. (1995). Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 11:199-210.
35. Lin, D., Shields, M. T., Ullrich, S. J., Appella, E., and Mercer, W. E. (1992). Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. Proc. Natl. Acad. Sci. USA 89:9210-9214.
36. Marek, L., Levresse, V., Amura, C., Zentrich, E., Van Putten, V., Nemenoff, R. A., and Heasley, L. E. (2004). Multiple signaling conduits regulate global differentiation-specific gene expression in PC12 cells. J. Cell. Physiol. 201:459-469.
37. Mohiuddin, L., Fernandez, K., Tomlinson, D. R., and Fernyhough, P. (1995). Nerve growth factor and neurotrophin-3 enhance neurite outgrowth and up-regulate the levels of messenger RNA for growth-associated protein GAP-43 and T alpha 1 alpha-tubulin in cultured adult rat sensory neurones. Neurosci. Lett. 185:20-23.
38. O'Driscoll, C. M., and Gorman, A. M. (2005). Hypoxia induces neurite outgrowth in PC12 cells that is mediated through adenosine A2A receptors. Neuroscience 131:321-329.
39. Ohmichi, M., Decker, S. J., Pang, L., and Saltiel, A. R. (1992). Inhibition of the cellular actions of nerve growth factor by staurosporine and K252A results from the attenuation of the activity of the trk tyrosine kinase. Biochemistry 31:4034-4039.
40. WAF1 regulates neuronal differentiation of PC12 cells. J. Biol. Chem. 272:24002-24007.
41. Przyborski, S. A., and Cambray-Deakin, M. A. (1994). Developmental changes in GAP-43 expression in primary cultures of rat cerebellar granule cells. Brain Res. Mol. Brain Res. 25:273-285.
42. Ramakers, G. M., De Graan, P. N., Urban, I. J., Kraay, D., Tang, T., Pasinelli, P., Oestreicher, A. B., and Gispen, W. H. (1995). Temporal differences in the phosphorylation state of pre- and postsynaptic protein kinase C substrates B-50/GAP-43 and neurogranin during long-term potentiation. J. Biol. Chem. 270:13892-13898.
43. Riese, U., Ziegler, E., and Hamburger, M. (2004). Militarinone A induces differentiation in PC12 cells via MAP and Akt kinase signal transduction pathways. FEBS Lett. 577:455-459.
44. Sah, V. P., Attardi, L. D, Mulligan, G. J., Williams, B. O., Bronson, R. T. and Jacks, T. (1995). A subset of p53-deficient embryos exhibit exencephaly. Nat. Genet. 10:175-180.
45. Schwamborn, J. C., Fiore, R., Bagnard, D., Kappler, J., Kaltschmidt, C., and Puschel, A. W. (2004). Semaphorin 3A stimulates neurite extension and regulates gene expression in PC12 cells. J. Biol. Chem. 279:30923-30926.
46. Shaulsky, G., Goldfinger, N., Peled, A., and Rotter, V. (1991). Involvement of wild-type p53 protein in the cell cycle requires nuclear localization. Cell Growth Differ. 2:661-667.
47. Skene, J. H., and Virag, I. (1989). Posttranslational membrane attachment and dynamic fatty acylation of a neuronal growth cone protein, GAP-43. J. Cell. Biol. 108:613-624.
48. Stanton, G., Boldogh, I., Georgiades, J. A., and Hughes, T. K. (2001). Induction of cell prolipheration and cytokines by colostrinin and component proline-rich peptides in human peripheral blood leukocytes. Psychogeriat. Annu. 4:67-75.
49. Sumantran, V. N. and Feldman, E. L. (1993). Insulin-like growth factor I regulates c-myc and GAP-43 messenger ribonucleic acid expression in SH-SY5Y human neuroblastoma cells. Endocrinology 132:2017-2023.
50. Szczesny, B., Bhakat, K. K., Mitra, S., and Boldogh, I. (2004). Age-dependent modulation of DNA repair enzymes by covalent modification and subcellular distribution. Mech. Ageing Dev. 125:755-765.
51. Szeberenyi, J. (1996). Gene activation pathways of nerve growth factor signaling: A minireview. Neurobiology (Bp) 4:1-11.
52. Tsukada, T., Tomooka, Y., Takai, S., Ueda, Y., Nishikawa, S., Yagi, T., Tokunaga, T., Takeda, N., Suda, Y. Abe, S., Matsuo, I., Ikawa, Y., and Aizawa, S. (1993). Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene 8:3313-3322.
53. Vaskovsky, A., Lupowitz, Z., Erlich, S., and Pinkas-Kramarski, R. (2000). ErbB-4 activation promotes neurite outgrowth in PC12 cells. J. Neurochem. 74:979-987.
54. Vaudry, D., Stork, P. J., Lazarovici, P., and Eiden, L. E. (2002). Signaling pathways for PC12 cell differentiation: Making the right connections. Science 296:1648-1649.
55. Weiss, R. H., and Randour, C. J. (2000). The permissive effect of p21 (Waf1/Cip1) on DNA synthesis is dependent on cell type: Effect is absent in p53-inactive cells. Cell. Signal 12:413-418.
56. Wood, K. W., Sarnecki, C., Roberts, T. M., and Blenis, J. (1992). ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1. and RSK. Cell 68:1041-1050.
57. Wu, Y. Y., and Bradshaw, R. A. (1996). Synergistic induction of neurite outgrowth by nerve growth factor or epidermal growth factor and interleukin-6 in PC12 cells. J. Biol. Chem. 271:13033-13039.
58. Xiao, J., and Liu, Y. (2003). Differential roles of ERK and JNK in early and late stages of neuritogenesis: a study in a novel PC12 model system. J. Neurochem. 86:1516-1523.
59. Yoo, Y. E., Hong, J. H., Hur, K. C., Oh, E. S., and Chung, J. M. (2004). Iron enhances NGF-induced neurite outgrowth in PC12 cells. Mol. Cells 17:340-346.
60. Zimecki, M., Lisowski, J., Hraba, T., Wieczorek, Z., Janusz, M., and Staroscik, K. (1984). The effect of a proline-rich polypeptide (PRP) on the humoral immune response. I. Distinct effect of PRP on the T cell properties of mouse glass-nonadherent (NAT) and glass-adherent (GAT) thymocytes in thymectomized mice. Arch. Immunol. Ther. Exp. (Warsz) 32:191-196.